GHK-Cu Research: 7 Key Findings on Copper Binding, Skin Biology and Cellular Repair
Exploring the copper-binding chemistry of GHK-Cu, its effects on skin cells, extracellular matrix signalling, wound research and the limits of human evidence.
GHK-Cu research examines how the copper-binding tripeptide glycyl-L-histidyl-L-lysine interacts with copper ions and influences biological processes associated with skin structure, extracellular matrix remodelling, inflammation and tissue repair.
Unlike many synthetic peptides discussed in laboratory research, GHK is also an endogenous molecule. It has been identified in human plasma and other biological fluids, and its capacity to bind copper(II) has attracted scientific attention for decades. GHK-Cu research
The copper complex, commonly written as GHK-Cu, has been studied in fibroblast cultures, animal wound models, skin-related experiments and selected human cosmetic investigations. GHK-Cu research
Early studies reported changes in collagen production and extracellular matrix components. Subsequent research explored the peptide’s relationship with copper coordination, oxidative stress, cellular signalling and gene-expression patterns.
However, the scientific evidence requires careful interpretation. GHK-Cu research
A result involving cultured fibroblasts does not demonstrate clinical skin regeneration. Likewise, a cosmetic study using a specific topical formulation does not establish the safety or effectiveness of an independently supplied research peptide.
Two systematic reviews published in 2026 highlighted this distinction. Both identified a substantial preclinical literature but comparatively limited, heterogeneous human evidence.
This guide examines seven important findings, from the chemistry of the GHK-Cu complex to its experimental effects and the analytical requirements for reliable laboratory research. GHK-Cu research
1. What Is GHK-Cu? Understanding the Copper Peptide
GHK is a tripeptide composed of three amino acids:
- Glycine (Gly)
- Histidine (His)
- Lysine (Lys)
Its sequence is written as:
Gly-His-Lys
or:
GHK
When GHK coordinates with copper(II), it forms a metal–peptide complex generally described as GHK-Cu.
The compound is also associated with the cosmetic ingredient designation copper tripeptide-1.
GHK and GHK-Cu Are Not Chemically Identical
GHK refers to the peptide without a copper ion explicitly bound to it.
GHK-Cu refers to a copper-coordinated form.
This distinction is important because the copper ion contributes to the chemical behaviour of the complex.
The presence of GHK in a sample does not automatically demonstrate that all of it is present as intact GHK-Cu.
Molecular Characteristics
| Property | Scientific description |
|---|---|
| Peptide name | Glycyl-L-histidyl-L-lysine |
| Abbreviation | GHK |
| Copper complex | GHK-Cu |
| Amino acid length | 3 |
| Peptide sequence | Gly-His-Lys |
| Approximate molecular mass of free GHK | 340.38 Da |
| Metal involved | Copper(II) |
| Research classification | Copper-binding tripeptide complex |
| Principal research areas | Skin biology, extracellular matrix, wound models, copper coordination and cellular signalling |
The exact molecular mass of a supplied GHK-Cu material depends on the declared chemical form, protonation state, counterions and other constituents. GHK-Cu research
A generic molecular-weight figure should not replace a product-specific analytical specification.
Is GHK Naturally Present in Humans?
GHK has been identified in human biological fluids, including plasma.
Researchers have also examined its relationship with extracellular matrix proteins and tissue-associated peptide fragments.
The fact that a peptide occurs naturally does not mean that concentrated or externally supplied preparations have established safety.
Why Is Copper Important?
Copper is an essential trace element involved in several biological processes.
Certain enzymes require copper as a cofactor. GHK-Cu research
However, free or loosely bound copper can also participate in reactions associated with oxidative stress.
The biological consequences depend on copper availability, coordination state and cellular environment.
What Makes GHK-Cu Scientifically Interesting?
GHK-Cu combines a short peptide sequence with metal-binding chemistry.
Researchers therefore study both its biological effects and its behaviour as a coordination complex.
This dual character makes chemical identification especially important.
2. GHK-Cu Copper Binding and Coordination Chemistry
The defining chemical characteristic of GHK-Cu is its interaction with copper(II).
Understanding that interaction is necessary before interpreting biological claims.
What Is Copper Coordination?
Copper coordination occurs when a copper ion interacts with electron-donating groups on surrounding molecules.
In peptide complexes, nitrogen-containing groups can participate in metal coordination.
GHK contains functional groups capable of interacting with copper(II), including groups associated with its histidine residue.
The Role of Histidine
Histidine contains an imidazole side chain.
The nitrogen atoms in this structure can participate in metal coordination.
This makes histidine-containing peptides particularly relevant to research involving metal-binding behaviour.
Is GHK-Cu Always a Single Fixed Chemical Species?
Not necessarily. GHK-Cu research
The distribution of copper-containing species can depend on conditions such as pH, concentration and the presence of competing ligands.
A formulation described as GHK-Cu may contain different proportions of intact complex, unbound peptide and other copper species.
Why Speciation Matters
Speciation describes the different chemical forms in which an element or compound exists.
For GHK-Cu research, the distinction between total copper and copper bound in a particular complex is important.
Two samples containing the same total amount of copper may not have identical coordination states.
Copper Binding vs Copper Delivery
It is tempting to describe GHK-Cu simply as a copper-delivery peptide.
However, copper binding, copper transport, intracellular copper availability and downstream biological effects are separate scientific questions.
A study demonstrating binding does not automatically establish efficient delivery into a particular cell compartment.
What Happens When Other Molecules Bind Copper?
Biological environments contain proteins, amino acids and other molecules capable of interacting with copper.
These can affect the distribution of copper-containing species.
As a result, the chemical form initially present in a laboratory preparation may not remain unchanged in every experimental environment.
Research Implications
A complete characterisation may need to consider both the peptide and its associated copper.
Measuring only total peptide content or total copper content may be insufficient to establish the amount of intact complex.
This issue was emphasised in a 2026 review examining GHK-Cu coordination chemistry, formulation and pharmaceutical characterisation.
3. GHK-Cu Research and Collagen Synthesis
One of the most established areas of preclinical GHK-Cu research concerns collagen and extracellular matrix biology.
Collagen is a family of structural proteins that contributes to the mechanical properties of skin, tendons, ligaments and other connective tissues. GHK-Cu research
What Do Fibroblasts Do?
Fibroblasts are cells involved in producing and remodelling extracellular matrix components.
In skin, they contribute to the organisation of collagen and other structural materials.
The 1988 Fibroblast Study
A study published in FEBS Letters in 1988 examined the effects of GHK-Cu on collagen synthesis in cultured fibroblasts.
The researchers reported stimulation of collagen production under their experimental conditions.
This finding helped establish the peptide complex as a subject of extracellular matrix research.
Does Increased Collagen Synthesis Mean Better Skin?
Not automatically.
Collagen synthesis is one component of tissue biology.
Normal skin function depends on collagen organisation, degradation, cross-linking and interactions with other matrix components.
Excessive collagen deposition may contribute to fibrosis.
Therefore, increased collagen production in a cell culture should not be equated with clinically beneficial skin regeneration.
Collagen Remodelling
The extracellular matrix is continuously remodelled. GHK-Cu research
New proteins are produced while existing components are degraded or reorganised.
The balance between these processes influences tissue structure.
Matrix Metalloproteinases
Matrix metalloproteinases, commonly abbreviated as MMPs, are enzymes involved in extracellular matrix degradation.
Their activity is regulated by several biological systems, including tissue inhibitors of metalloproteinases.
GHK-related research has examined changes in these pathways.
Why Balance Matters
A compound that changes collagen synthesis without appropriate remodelling could produce different outcomes depending on the tissue environment.
The biological objective is not simply maximum collagen production.
It is coordinated tissue maintenance and organisation.
What Has Been Established?
GHK-Cu can influence collagen-related outcomes in selected laboratory systems.
Whether those changes produce consistent, clinically meaningful benefits in humans remains a separate question requiring controlled clinical evidence.
4. GHK-Cu, Glycosaminoglycans and Extracellular Matrix Organisation
The extracellular matrix contains more than collagen.
It also includes glycosaminoglycans and proteoglycans, which contribute to tissue hydration, structure and signalling. GHK-Cu research
What Are Glycosaminoglycans?
Glycosaminoglycans are long carbohydrate chains associated with the extracellular matrix.
Examples include hyaluronic acid, chondroitin sulfate and dermatan sulfate.
Their physical and chemical properties contribute to the behaviour of connective tissues.
What Are Proteoglycans?
Proteoglycans are molecules composed of a protein core associated with glycosaminoglycan chains.
They participate in extracellular matrix organisation and interactions between cells and their environment.
Decorin and Biglycan
Decorin and biglycan are small leucine-rich proteoglycans involved in extracellular matrix biology.
They have been studied in relation to collagen fibril organisation and tissue responses.
The 2000 Wound Model Study
A study published in the Journal of Investigative Dermatology examined GHK-Cu in rat wound models and rat dermal fibroblast cultures.
The researchers reported changes in glycosaminoglycan production and expression of selected proteoglycans.
These included differences involving decorin and biglycan. GHK-Cu research
Why This Finding Matters
It suggests that GHK-Cu-associated extracellular matrix responses are not limited to collagen synthesis.
The peptide complex may influence several components of matrix organisation. GHK-Cu research
Does This Establish Human Wound Healing?
No.
The study involved experimental animal tissues and cultured cells.
The results support further investigation but do not establish clinical wound-healing effectiveness in humans.
Research Applications
These findings are relevant to laboratory questions involving matrix composition, fibroblast responses and tissue remodelling.
They also demonstrate why a single biomarker cannot capture the full complexity of tissue repair. GHK-Cu research
5. GHK-Cu Antioxidant and Inflammatory Signalling Research
GHK-Cu has been examined in relation to oxidative stress and inflammatory pathways.
These topics are often discussed together, but they represent different biological processes.
What Is Oxidative Stress?
Oxidative stress occurs when reactive chemical species and the systems that regulate them become imbalanced.
Reactive oxygen species participate in normal cellular signalling.
At excessive levels or in inappropriate contexts, they may contribute to cellular damage.
Copper and Redox Chemistry
Copper can participate in electron-transfer reactions.
Its biological effects depend partly on how it is coordinated and regulated.
Consequently, copper-containing compounds should not automatically be classified as antioxidants under all conditions. GHK-Cu research
GHK-Cu and Antioxidant Research
Preclinical studies and reviews have described GHK-Cu-associated changes in oxidative stress markers and antioxidant defence pathways.
These observations provide a basis for investigating the complex in different cellular systems.
Inflammatory Signalling
Inflammation involves coordinated responses by immune cells, signalling molecules and affected tissues.
It can contribute to both tissue protection and tissue damage.
NF-κB
NF-κB refers to a family of transcription factors involved in immune and inflammatory gene regulation.
Some GHK-Cu research has examined changes associated with NF-κB-related signalling.
Nrf2
Nrf2 is a transcription factor involved in regulating cellular responses to oxidative and electrophilic stress.
It is relevant to the study of antioxidant defence mechanisms.
Are These Direct GHK-Cu Targets?
Changes in NF-κB or Nrf2 activity do not establish that GHK-Cu binds these proteins directly.
The observed effects may involve indirect signalling. GHK-Cu research
Why Context Matters
A change in an inflammatory marker may be beneficial, neutral or harmful depending on the experimental system.
Inflammation is also necessary for normal tissue responses.
Suppressing every inflammatory signal is not a scientifically meaningful definition of tissue repair.
The Evidence Boundary
GHK-Cu has demonstrated interesting effects in selected experimental models.
The available findings do not establish it as a clinically proven treatment for inflammatory or oxidative stress-related diseases. GHK-Cu research
6. GHK-Cu Skin Research, Wound Models and Human Clinical Evidence
GHK-Cu is widely discussed in skin research because of its effects on fibroblasts, extracellular matrix components and experimental wound responses. GHK-Cu research
However, the human evidence base is smaller than the laboratory literature.
Skin Structure and Function
Skin contains several layers with different cellular and structural characteristics.
The epidermis provides an important barrier, while the dermis contains collagen-rich connective tissue and other matrix components.
GHK-Cu and Skin Cells
Preclinical investigations have examined fibroblast activity, keratinocyte responses and extracellular matrix production.
These findings are relevant to skin biology but do not establish clinical benefits on their own.
Experimental Wound Research
Animal studies have investigated GHK-Cu-associated changes in wound tissue and matrix organisation.
These models can reveal biological mechanisms under controlled conditions.
However, animal wound responses differ from those of human skin.
Human Cosmetic Research
Small clinical studies have examined GHK-Cu-containing topical formulations in cosmetic settings.
Some have reported improvements in selected appearance-related outcomes.
The studies differ in formulation, methods, participant numbers and outcome measurements.
What Did the 2026 Systematic Reviews Find?
A 2026 systematic review published in Aesthetic Surgery Journal included 20 studies, comprising 18 preclinical investigations and two randomised controlled trials.
The authors reported encouraging preclinical findings but emphasised the limited number of well-designed clinical studies.
Another 2026 review examining topical and microneedle-related GHK-Cu research identified 64 records for qualitative synthesis.
It highlighted substantial variation in the available human evidence and the need for more rigorous trials.
Not Every Human Study Was Positive
A small randomised study involving skincare regimens after carbon dioxide laser resurfacing did not demonstrate a significant objective advantage on its principal assessed skin outcomes, although patient satisfaction differed.
This is an important reminder that biological plausibility does not guarantee measurable clinical benefit.
Why Formulation Matters
A topical product, a laboratory solution and a material used in a delivery-system experiment may differ substantially.
The skin barrier can also affect the movement of compounds into deeper tissues. GHK-Cu research
What About Microneedle Delivery?
Researchers have investigated technologies intended to improve transport across the skin barrier.
Some laboratory and ex vivo studies report increased GHK-Cu delivery with such systems.
These findings do not establish the clinical effectiveness or safety of every delivery method.
What About Hair Research?
GHK-Cu has also been examined in hair-related experimental and small human cosmetic studies.
A 2026 review described an 18-participant split-face eyebrow study reporting favourable cosmetic outcomes.
However, the sample was small, and important formulation and chemical-speciation questions remained unresolved.
Is GHK-Cu Proven to Reverse Skin Ageing?
No.
There is scientific evidence supporting selected biological effects and limited clinical evidence for particular cosmetic formulations.
That does not establish comprehensive reversal of skin ageing or general clinical effectiveness.
7. GHK-Cu Analytical Testing: Identity, Copper Content and Stability
GHK-Cu research requires more than confirming that a sample contains a tripeptide.
Because the material is a metal–peptide complex, analytical characterisation should consider both the peptide and the copper-containing species.
Confirming Peptide Identity
Analytical methods can be used to evaluate whether the peptide sequence is consistent with glycyl-L-histidyl-L-lysine.
Mass spectrometry may provide supporting evidence of molecular identity. GHK-Cu research
Measuring Peptide Purity
High-performance liquid chromatography can separate peptide-related components under defined analytical conditions.
However, a chromatographic purity result does not automatically establish the proportion of intact copper-bound complex.
Measuring Copper Content
Elemental analysis can provide information about the total copper present in a sample.
Techniques such as inductively coupled plasma mass spectrometry may be relevant.
Total Copper vs Bound Copper
Total copper measurement does not distinguish every chemical form in which copper is present.
The proportion associated with intact GHK-Cu may require additional analysis.
Why Orthogonal Testing Matters
Orthogonal testing uses methods that provide different kinds of analytical information.
For example, a laboratory may need separate evidence concerning peptide identity, total copper and the distribution of copper-containing species.
Stability and Degradation
GHK-Cu behaviour can depend on formulation conditions.
Relevant factors may include pH, competing ligands, light exposure and other environmental conditions.
Storage recommendations should be based on data applicable to the specific formulation.
Colour Is Not Proof of Purity
Copper-containing complexes may display characteristic colours.
However, appearance alone cannot establish identity, purity, concentration or the absence of contaminants.
Certificates of Analysis
A meaningful batch-specific Certificate of Analysis should identify the intended material and describe the tests performed.
For a copper peptide, the analytical specification should be appropriate to the actual chemical form.
Sterility and Endotoxins
Peptide identity and chromatographic purity do not establish sterility or endotoxin status.
These are separate quality attributes.
Why This Matters for Biological Experiments
Unbound copper, degradation products or other constituents may affect experimental results. GHK-Cu research
Without adequate characterisation, a biological response may be incorrectly attributed to intact GHK-Cu.
GHK-Cu Research: Evidence Strength by Application
| Research area | Evidence type | Interpretation |
|---|---|---|
| Copper coordination | Chemical and analytical studies | Established ability of GHK to bind copper |
| Fibroblast collagen synthesis | Cell-culture studies | Experimental changes reported |
| Glycosaminoglycan production | Cell and animal studies | Preclinical matrix effects reported |
| Wound tissue organisation | Primarily animal studies | Findings warrant further investigation |
| Antioxidant signalling | Preclinical studies | Context-dependent effects proposed |
| Inflammatory pathways | Laboratory and animal studies | Mechanisms remain incompletely characterised |
| Cosmetic skin outcomes | Small human studies | Limited, heterogeneous clinical evidence |
| Hair-related cosmetic outcomes | Early clinical and preclinical studies | Larger controlled studies needed |
| Human wound treatment | Insufficient definitive trials | Clinical effectiveness not established |
| Long-term safety | Limited human evidence | Not adequately established for all formulations and uses |
Worked Example: Why Two GHK-Cu Samples May Not Be Equivalent
Consider two hypothetical research materials.
Both are labelled GHK-Cu and have similar nominal peptide quantities. GHK-Cu research
| Analytical characteristic | Sample A | Sample B |
|---|---|---|
| Declared peptide | GHK | GHK |
| Total peptide | 10 mg | 10 mg |
| Total copper | Reported | Reported |
| Peptide identity testing | Available | Available |
| Copper coordination analysis | Available | Not supplied |
| Labile copper assessment | Available | Not supplied |
| Batch-specific documentation | Available | Available |
This table is a fictional teaching example and does not describe actual supplier products.
Are the Samples Chemically Equivalent?
The information is insufficient to establish equivalence.
Both may contain GHK and copper, but the amount of intact complex has not been characterised to the same extent.
Does Similar Total Peptide Content Prove Similar Biological Activity?
No.
Differences in copper coordination, impurities or formulation may influence experimental behaviour.
What Is the Stronger Documentation Package?
Sample A provides more information about copper-related attributes.
However, the quality of its documentation still depends on the methods, validation and actual results.
The Main Lesson
For GHK-Cu, peptide purity and total copper content are useful but may not fully describe the active chemical species.
Researchers should match analytical evidence to the intended scientific question.
GHK-Cu and Other Peptide Research Compounds
GHK-Cu is sometimes discussed alongside BPC-157 and TB-500.
These compounds differ substantially in molecular identity and available evidence.
| Compound | Molecular characteristic | Main research distinction |
|---|---|---|
| GHK-Cu | Copper-binding tripeptide complex | Metal coordination and extracellular matrix biology |
| BPC-157 | Synthetic 15-amino-acid peptide | Primarily preclinical tissue-response research |
| TB-500 | Commercial designation associated with thymosin beta-4-related materials | Precise molecular identity requires verification |
| Full-length thymosin beta-4 | Endogenous 43-amino-acid peptide | Actin-binding and cell-migration biology |
These distinctions matter when interpreting experiments involving individual peptides or combinations.
Results from separate studies do not establish the biological effects of a blend. GHK-Cu research
Related Axion Peptide Lab research guides:
BPC-157 Tissue Repair Research
TB-500 Research and Thymosin Beta-4
Peptide Certificate of Analysis
Confirm these planned internal article URLs are published before adding them as live links.
GHK-Cu Research Materials at Axion Peptide Lab
Axion Peptide Lab provides a catalogue of compounds for laboratory and analytical research.
Researchers evaluating copper peptides should consult current product specifications and available batch documentation.
What Should Laboratories Verify?
The relevant information may include the declared peptide sequence, copper-associated chemical form, nominal content, analytical methods and batch identity.
Does a 99% Purity Claim Establish Complete GHK-Cu Characterisation?
No.
A chromatographic purity percentage does not necessarily establish total peptide content, copper occupancy, labile copper or sterility.
Why Product-Specific Documentation Matters
Results from published studies concern particular compounds and formulations.
They do not automatically validate independently supplied research materials.
Research-Only Distinction
GHK-Cu research materials should not be represented as approved medicines or as interchangeable with cosmetic formulations evaluated in clinical studies.
Frequently Asked Questions About GHK-Cu Research
1. What is GHK-Cu?
GHK-Cu is a copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, studied for its coordination chemistry and effects on cellular and extracellular matrix biology.
2. What is the GHK-Cu amino acid sequence?
The peptide sequence is Gly-His-Lys, abbreviated GHK.
3. Is GHK-Cu the same as GHK?
Not exactly. GHK is the peptide, while GHK-Cu describes its copper-coordinated form.
4. How does GHK-Cu affect collagen?
Selected fibroblast studies have reported changes in collagen synthesis following GHK-Cu exposure. These findings do not independently establish clinical skin regeneration.
5. Does GHK-Cu affect extracellular matrix proteins?
Yes, preclinical studies have reported changes in collagen-related outcomes, glycosaminoglycans and selected proteoglycans.
6. Is GHK-Cu proven to reverse skin ageing?
No. Some small cosmetic studies report favourable outcomes, but the human evidence remains limited and heterogeneous.
7. What is the role of copper in GHK-Cu?
Copper participates in coordination with the peptide and contributes to the chemical characteristics of the complex. The biological consequences depend on the chemical and experimental environment.
8. Can HPLC alone confirm GHK-Cu purity?
HPLC can provide chromatographic information, but it does not automatically establish the amount of intact copper-bound complex or all other quality attributes.
9. Are there human clinical studies of GHK-Cu?
Yes. Small human studies have examined particular topical formulations and cosmetic outcomes. Larger, well-controlled trials are still needed.
10. Is GHK-Cu an approved treatment for wound healing?
GHK-Cu is not established as an approved human wound-healing medicine on the basis of the research discussed here. Independently supplied research materials should not be used as substitutes for approved medical treatments.
Conclusion: What GHK-Cu Research Establishes
GHK-Cu research connects peptide coordination chemistry with experimental observations involving fibroblasts, extracellular matrix components, oxidative stress and skin-related biology.
The ability of GHK to bind copper is a well-established chemical property.
Laboratory studies have also reported changes in collagen synthesis, glycosaminoglycan production and other tissue-associated processes.
These findings provide a scientific basis for continued investigation.
However, the available human clinical evidence remains limited, and results from one formulation or experimental model cannot automatically be applied to another.
The 2026 systematic reviews reinforce the need for larger controlled studies and better chemical characterisation of the materials being tested.
For laboratories, reliable GHK-Cu research depends on precise identification of the peptide, appropriate copper-related analysis, batch documentation and careful interpretation of biological outcomes.
GHK-Cu is a scientifically interesting copper-binding peptide complex, but its preclinical potential should not be confused with established human therapeutic effectiveness.
Scientific References
- Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺. FEBS Letters, 238(2), 343–346.
https://doi.org/10.1016/0014-5793(88)80509-X - Siméon A, Wegrowski Y, Bontemps Y, Maquart FX. (2000). Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺. Journal of Investigative Dermatology, 115(6), 962–968.
https://doi.org/10.1046/j.1523-1747.2000.00166.x - Pickart L, Margolina A. (2015). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International.
https://pubmed.ncbi.nlm.nih.gov/26236730/ - Najafi N, Maatouk H, Vardanyan KG, Vartanian KB, Agrawal DK. (2026). A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu in Topical Microneedle Delivery: A Case for Expanded Clinical Trials. Archives of Internal Medicine Research, 9(3), 269–293.
https://doi.org/10.26502/aimr.0255 - Regenerative Potential of Glycyl-L-Histidyl-L-Lysine–Copper in Aesthetic Medicine. (2026). Aesthetic Surgery Journal.
https://doi.org/10.1093/asj/sjag169 - GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap. (2026). Pharmaceutics, 18(9), 1077.
https://doi.org/10.3390/pharmaceutics18091077 - PubMed. Biomedical research database for GHK-Cu and copper peptide studies.
https://pubmed.ncbi.nlm.nih.gov/?term=GHK-Cu
These references support the discussion of published scientific findings. They do not verify the identity, purity, safety or suitability for human use of any independently supplied research product.
Research-use notice: This article is provided for scientific education and legitimate laboratory research. Axion Peptide Lab research materials are not intended for human or veterinary administration. Experimental findings and limited cosmetic clinical evidence should not be interpreted as established medical claims, administration guidance or proof of human therapeutic benefit.